You'll see on twitter Napadano sees the same thing I see. That AMBS has MSA with Icon now, but that after data, ICON will likely be the full partner as proxy for pfizer etc that we were all expecting. Scenario where ICON gets some rights to Lympro and pays us which is why GC said in blog following announcement "at the current time."

Vicente Christian ‏@ViChristi 2h
@JNapodano what happen with JV partner for $AMBS

Jason Napodano, CFA ‏@JNapodano 1h
@vichristi Sounds like it will be ICON Labs but they need to generate more data first. Right now $AMBS is paying ICON. That will flip soon.